Does Rallies show Form 4 insider transactions for GUTS?

Yes. Rallies tracks GUTS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GUTS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GUTS. It does not provide personalized investment advice.

GUTS (Fractyl Health, Inc. Common Stock) Stock Analysis - Insider Trades

Fractyl Health, Inc. Common Stock (GUTS) is a publicly traded Healthcare sector company. As of May 21, 2026, GUTS trades at $0.89 with a market cap of $127.93M and a P/E ratio of -0.47. GUTS moved +12.56% today. Year to date, GUTS is -55.28%; over the trailing twelve months it is -56.13%. Its 52-week range spans $0.38 to $3.48. Analyst consensus is strong buy with an average price target of $5.00. Rallies surfaces GUTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GUTS stock inside the company?

Recent GUTS insider activity includes Rajagopalan Harith bought 10.42K, Royan Ajay bought 17.90K, Barnes Kelly Ann bought 31.00K, SCHULMAN AMY W bought 8.55K, and BRADLEY WILLIAM bought 16.13K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GUTS Key Metrics

Key financial metrics for GUTS
Metric	Value
Price	$0.89
Market Cap	$127.93M
P/E Ratio	-0.47
EPS	$-1.86
Dividend Yield	0.00%
52-Week High	$3.48
52-Week Low	$0.38
Volume	8.01K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-140.95M
Gross Margin	0.00%

Recent GUTS Insider Trades

Rajagopalan Harith bought 10.42K (~$20.00K) on Dec 4, 2025.
Royan Ajay bought 17.90K (~$22.98K) on Mar 14, 2025.
Barnes Kelly Ann bought 31.00K (~$40.21K) on Mar 14, 2025.
SCHULMAN AMY W bought 8.55K (~$9.96K) on Mar 13, 2025.
BRADLEY WILLIAM bought 16.13K (~$20.36K) on Mar 13, 2025.

Latest GUTS News

Fractyl Health Secures Runway into Early 2027, Anticipates Q4 Pivotal Readout — May 12, 2026
Fractyl Health Gains Dutch Nod for Phase 1/2 RJVA-001 Gene Therapy Trial — May 11, 2026
Fractyl Health Poised for Growth as Cell Therapy Market Doubles to $14B — Mar 27, 2026
Fractyl Health’s Q4 Loss Widens to $43.7M, Cash Runway to Early 2027 — Mar 25, 2026
Fractyl Health Completes REMAIN-1 Randomization After Positive Dose-Dependent Revita Results — Mar 24, 2026

GUTS Analyst Consensus

4 analysts cover GUTS: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.00.

Common questions about GUTS

Who is trading GUTS stock inside the company?: Recent GUTS insider activity includes Rajagopalan Harith bought 10.42K, Royan Ajay bought 17.90K, Barnes Kelly Ann bought 31.00K, SCHULMAN AMY W bought 8.55K, and BRADLEY WILLIAM bought 16.13K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GUTS?: Yes. Rallies tracks GUTS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GUTS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GUTS. It does not provide personalized investment advice.